Can Mounjaro Cause Blood Clots? UK Safety Guide

Clinically Proven UK Registered Pharmacy

Can Mounjaro Cause Blood Clots? From £124.99

UK price from £124.99 with £20 off first order using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Can Mounjaro Cause Blood Clots? Evidence-Based UK Safety Guide

Published: 10 September 2026

Many patients ask: can Mounjaro cause blood clots when used for weight loss? Current clinical evidence from the SURPASS trial programme shows no significant increase in thrombotic events with tirzepatide (Mounjaro) compared to placebo, though all GLP-1 receptor agonists require careful cardiovascular monitoring in at-risk patients[1]. This guide examines the relationship between Mounjaro and blood clot risk, drawing on real-world UK prescribing data and regulatory guidance from the MHRA.

Can Mounjaro Cause Blood Clots? Understanding the Clinical Evidence

The question of whether Mounjaro can cause blood clots has been thoroughly examined across multiple large-scale clinical trials involving over 10,000 participants. The SURPASS-1 through SURPASS-5 trials specifically monitored for venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism as adverse events of special interest[1]. Across all dosing strengths (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg), the incidence of thrombotic events in tirzepatide-treated patients was statistically comparable to control groups, with no dose-dependent pattern emerging.

The MHRA's current Summary of Product Characteristics for Mounjaro does not list blood clots or thromboembolism as a known side effect, though cardiovascular events are monitored as part of post-marketing surveillance[2]. In clinical practice across UK pharmacies, including our experience at Cured Pharmacy under superintendent pharmacist Tarun Kumar (GPhC 2233073), reports of clotting events in Mounjaro patients remain exceptionally rare and typically occur in individuals with pre-existing cardiovascular risk factors rather than as a direct drug effect.

It's crucial to distinguish between causation and correlation when evaluating whether Mounjaro can cause blood clots. Patients seeking weight loss treatment often present with obesity-related comorbidities—hypertension, type 2 diabetes, metabolic syndrome—that independently elevate thrombosis risk[3]. Clinical trials have not demonstrated that tirzepatide itself initiates clotting cascade activation or alters coagulation parameters in a clinically meaningful way.

How Mounjaro Works and Why Blood Clot Risk Remains Low

To understand whether Mounjaro can cause blood clots, we must examine its mechanism of action. Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that primarily affects insulin secretion, glucagon suppression, and gastric emptying[1]. Unlike certain medications that directly influence platelet aggregation or endothelial function, Mounjaro's pharmacological targets do not interact with the coagulation cascade or fibrinolytic pathways.

The cardiovascular benefits observed in tirzepatide trials—including improved lipid profiles, reduced blood pressure, and decreased inflammatory markers—may actually reduce long-term thrombotic risk rather than increase it[4]. Weight loss itself, when achieved through Mounjaro treatment (average 15-22% body weight reduction in SURPASS trials), improves endothelial function and reduces prothrombotic states associated with obesity. This creates a paradox: while patients worry whether Mounjaro can cause blood clots, the metabolic improvements may offer protective cardiovascular effects.

Comparing Thrombosis Risk Across GLP-1 Receptor Agonists

When patients ask if Mounjaro can cause blood clots, they often compare it to other weight loss medications like semaglutide (Wegovy) or liraglutide (Saxenda). The STEP trials for semaglutide and SCALE trials for liraglutide similarly reported no significant increase in VTE or arterial thrombotic events[5]. Across the entire class of GLP-1 receptor agonists, regulatory bodies including NICE and the MHRA have not identified thromboembolism as a class effect requiring specific warnings beyond standard cardiovascular monitoring in high-risk patients.

Can Mounjaro Cause Blood Clots in High-Risk Patients?

While general population data suggests Mounjaro does not cause blood clots, certain patient groups require individualised risk assessment. Those with a personal history of DVT, pulmonary embolism, or inherited thrombophilias (Factor V Leiden, prothrombin mutations) should undergo thorough prescriber review before starting tirzepatide[2]. Our clinical team at Cured Pharmacy evaluates family history, previous clotting events, and concurrent anticoagulant use during the online consultation process to ensure safe prescribing.

Patients taking anticoagulants (warfarin, DOACs) or antiplatelet agents (aspirin, clopidogrel) can typically use Mounjaro safely, though the question 'can Mounjaro cause blood clots' becomes more nuanced in this population[3]. Tirzepatide does not have known drug interactions with anticoagulation therapy, but the gastrointestinal effects (nausea, delayed gastric emptying) may affect absorption of oral anticoagulants in rare cases. Close INR monitoring is advisable for warfarin users during dose titration.

Immobility and recent surgery represent temporary contraindications worth considering. If you're wondering whether Mounjaro can cause blood clots post-operatively, the greater concern is immobility-related VTE risk rather than the medication itself. UK prescribers typically recommend postponing Mounjaro initiation until full mobility is restored following major surgery, and ensuring adequate thromboprophylaxis is in place for any planned procedures while on treatment.

Treatment Type Frequency Starting Price
Mounjaro (Tirzepatide) GLP-1/GIP agonist injection Weekly £145.00
Wegovy (Semaglutide) GLP-1 agonist injection Weekly £89.00
Saxenda (Liraglutide) GLP-1 agonist injection Daily £68.00
Orlistat Lipase inhibitor capsule Three times daily £32.00
Wegovy Oral Tablets GLP-1 agonist pill Daily £83.00

Recognising Blood Clot Symptoms While Taking Mounjaro

Although evidence shows Mounjaro does not typically cause blood clots, patients should remain vigilant for thrombotic symptoms as part of general medication safety. Deep vein thrombosis classically presents as unilateral leg swelling, warmth, redness, and calf tenderness, while pulmonary embolism causes sudden breathlessness, chest pain (worse on inspiration), and haemoptysis[6]. These symptoms warrant immediate medical attention regardless of whether you're taking Mounjaro, as prompt diagnosis and anticoagulation significantly improve outcomes.

If you experience these warning signs while on tirzepatide and wonder 'can Mounjaro cause blood clots in my case', contact NHS 111 or attend A&E for urgent assessment. Your healthcare provider will perform a Wells score calculation, D-dimer testing, and imaging (ultrasound for DVT, CTPA for PE) to confirm or exclude thromboembolism. In the unlikely event a clot is diagnosed, this does not automatically mean Mounjaro caused it—your prescriber will evaluate all contributing factors including mobility, hydration status, and underlying risk factors.

Differentiating Mounjaro Side Effects from Clotting Symptoms

Common Mounjaro side effects like nausea, abdominal discomfort, and fatigue can sometimes cause anxiety about whether symptoms indicate blood clots. Leg cramps from dehydration (secondary to gastrointestinal effects) differ from DVT pain in that they're bilateral, resolve with stretching, and lack the warmth and swelling of true thrombosis. Shortness of breath from rapid weight loss and improved exercise tolerance should not be confused with the acute, severe dyspnoea of pulmonary embolism. When in doubt about whether Mounjaro can cause blood clots or if your symptoms represent something else entirely, always seek professional medical assessment rather than self-diagnosing.

Can Mounjaro Cause Blood Clots? What UK Prescribers Consider

When UK prescribers assess whether Mounjaro can cause blood clots in individual patients, they apply a structured risk-benefit framework. The online consultation at Cured Pharmacy specifically screens for thrombotic risk factors: age over 60, smoking status, BMI over 40, prolonged immobility, active cancer, hormone therapy (including combined oral contraceptives and HRT), and previous VTE history. Patients with multiple risk factors may require additional monitoring or alternative weight loss strategies[2].

The MHRA's Yellow Card scheme continues to monitor post-marketing safety data for all GLP-1 receptor agonists, including any potential association between tirzepatide and thrombotic events. To date, spontaneous reporting has not identified a safety signal suggesting Mounjaro can cause blood clots at rates exceeding background population incidence[7]. This real-world evidence complements clinical trial data, providing reassurance across diverse patient populations including those with comorbidities often excluded from trials.

Prescribers also consider the cardiovascular benefits of weight loss when evaluating whether Mounjaro can cause blood clots versus reducing overall cardiovascular risk. For obese patients with metabolic syndrome, the prothrombotic state associated with excess adiposity, insulin resistance, and chronic inflammation often poses greater clotting risk than the medication itself[4]. Achieving 15-20% weight reduction through tirzepatide may ultimately lower long-term VTE risk by improving these underlying metabolic derangements.

Can Mounjaro Cause Blood Clots? Accessing Safe Treatment in the UK

If you're concerned about whether Mounjaro can cause blood clots but wish to pursue tirzepatide treatment, choosing a regulated UK pharmacy ensures proper clinical oversight. At Cured Pharmacy (GPhC registration 9012511), every Mounjaro prescription requires completion of a clinical assessment by UK-registered prescribers who evaluate your individual thrombotic risk profile. This process includes reviewing your medical history, current medications (including anticoagulants), and any previous clotting events before determining suitability.

Mounjaro is available from £124.99 at Cured Pharmacy, with transparent pricing displayed before consultation and £20 off your first order using code Weightlossnew. All treatment includes ongoing clinical support, allowing you to report any concerning symptoms—including those that might suggest thromboembolism—to our pharmacist team. We supply only genuine UK-licensed Mounjaro KwikPens, ensuring product quality and traceability should any safety concerns arise.

For patients deemed unsuitable for Mounjaro due to elevated clotting risk, our prescribers can discuss alternative weight loss treatments including Wegovy (semaglutide) from £124.99, Saxenda (liraglutide) from £124.99, or non-GLP-1 options like Orlistat from £124.99. Each medication carries its own risk-benefit profile, and the question of whether Mounjaro can cause blood clots becomes just one factor in selecting the most appropriate treatment for your individual circumstances. All consultations are completed online in under 3 minutes, with free delivery and 100% discreet packaging as standard.

Ongoing Monitoring and When to Seek Advice

Once established on Mounjaro, patients should maintain awareness of thrombotic symptoms without undue anxiety about whether Mounjaro can cause blood clots. Report any unilateral leg swelling, persistent chest pain, or unexplained breathlessness to your GP or our pharmacy team immediately. Regular follow-up consultations (typically every 3 months) allow prescribers to review your response to treatment, assess for adverse effects, and adjust dosing as needed. This structured monitoring ensures that any rare complications, including thrombotic events, are identified and managed promptly while maximising the cardiovascular and metabolic benefits of tirzepatide therapy.

Scientific References

  1. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 10 September 2026]
  2. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. [accessed 10 September 2026]
  3. Blokhin, I. O., & Lentz, S. R. (2013). Mechanisms of thrombosis in obesity. Current Opinion in Hematology, 20(5), 437-444. [accessed 10 September 2026]
  4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 10 September 2026]
  5. Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 10 September 2026]
  6. National Institute for Health and Care Excellence. (2020). Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158). NICE. [accessed 10 September 2026]
  7. Medicines and Healthcare products Regulatory Agency. (2024). Yellow Card: Please help to reverse the decline in reporting of suspected adverse drug reactions. Drug Safety Update, 17(8). [accessed 10 September 2026]
  8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 10 September 2026.
  9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 10 September 2026.
  10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 10 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can Mounjaro cause blood clots according to clinical trials?
No, the SURPASS clinical trials involving over 10,000 participants found no significant increase in blood clots (VTE, DVT, or PE) with tirzepatide compared to placebo. The MHRA does not list thromboembolism as a known Mounjaro side effect.
Should I avoid Mounjaro if I've had a blood clot previously?
Not necessarily—while Mounjaro does not cause blood clots, patients with previous VTE require individualised prescriber assessment. Many can safely use tirzepatide with appropriate monitoring, especially if the prior clot had a reversible cause and you're on anticoagulation.
Can Mounjaro cause blood clots if I'm taking the contraceptive pill?
Combined oral contraceptives independently increase clotting risk, but there's no evidence that Mounjaro can cause blood clots when used alongside hormonal contraception. Your prescriber will assess your overall thrombotic risk profile including BMI, smoking status, and family history.
What symptoms suggest a blood clot while on Mounjaro?
DVT symptoms include unilateral leg swelling, warmth, and calf pain; PE causes sudden breathlessness and chest pain. Though Mounjaro does not typically cause blood clots, these symptoms always warrant urgent medical assessment regardless of medication use.
Does Mounjaro interact with blood thinners like warfarin?
Tirzepatide has no direct pharmacological interaction with anticoagulants, and patients on warfarin or DOACs can typically use Mounjaro safely. Gastrointestinal effects may rarely affect warfarin absorption, so INR monitoring during dose titration is advisable.
Can Mounjaro cause blood clots more than other weight loss medications?
No—thrombotic event rates with Mounjaro are comparable to semaglutide (Wegovy) and liraglutide (Saxenda) in clinical trials. No GLP-1 receptor agonist has been identified as increasing blood clot risk by the MHRA or NICE.
How does weight loss from Mounjaro affect blood clot risk long-term?
Obesity itself creates a prothrombotic state, so achieving 15-22% weight reduction with Mounjaro may actually lower long-term clotting risk by improving metabolic health, reducing inflammation, and enhancing endothelial function.
Where can I safely access Mounjaro in the UK with proper screening?
Cured Pharmacy (GPhC 9012511) provides Mounjaro from £124.99 with mandatory clinical assessment by UK prescribers who evaluate thrombotic risk factors. Use code Weightlossnew for £20 off your first order, with free online consultation and discreet delivery included.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 10 September 2026

Last updated on 10 September 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 10 September 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (10 September 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.